ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Metagenomi Inc

Metagenomi Inc (MGX)

6.39
-0.01
(-0.16%)
Closed May 31 4:00PM
6.39
0.00
(0.00%)
After Hours: 4:02PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
6.39
Bid
5.97
Ask
6.86
Volume
22,139
6.28 Day's Range 6.63
5.50 52 Week Range 12.74
Market Cap
Previous Close
6.40
Open
6.49
Last Trade Time
Financial Volume
$ 141,289
VWAP
6.3819
Average Volume (3m)
116,967
Shares Outstanding
37,527,695
Dividend Yield
-
PE Ratio
-3.52
Earnings Per Share (EPS)
-1.82
Revenue
44.76M
Net Profit
-68.26M

About Metagenomi Inc

At Metageno­mi, we are cre­at­ing poten­tial­ly cura­tive ther­a­peu­tics using our metage­­nomics-pow­ered genome edit­ing toolbox.We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of geno... At Metageno­mi, we are cre­at­ing poten­tial­ly cura­tive ther­a­peu­tics using our metage­­nomics-pow­ered genome edit­ing toolbox.We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing asuite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was $6.40. Over the last year, Metagenomi shares have traded in a share price range of $ 5.50 to $ 12.74.

Metagenomi currently has 37,527,695 shares outstanding. The market capitalization of Metagenomi is $240.55 million. Metagenomi has a price to earnings ratio (PE ratio) of -3.52.

MGX Latest News

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

EMERYVILLE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational development program in Hemophilia A; development candidate nomination anticipated in mid-year...

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

EMERYVILLE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi to Present at Upcoming Scientific Meetings

-   Oral Presentation at World Federation of Hemophilia (WFH) World Congress, April 23, 2024 -   Two Posters at American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, May 8 &...

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.91-12.46575342477.37.656.1421446.51763437CS
40.050.7886435331236.347.655.51074596.42304288CS
12-5.92-48.090982940712.3112.3555.51169678.57450804CS
26-3.86-37.658536585410.2512.745.51688549.90037246CS
52-3.86-37.658536585410.2512.745.51688549.90037246CS
156-3.86-37.658536585410.2512.745.51688549.90037246CS
260-3.86-37.658536585410.2512.745.51688549.90037246CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SMMTSummit Therapeutics Inc
$ 10.92
(272.06%)
31.99M
INXBInhibrx Biosciences Inc
 15.85
(99.87%)
725.03k
JCSEJE Cleantech Holdings Limited
$ 1.23
(73.24%)
43.01M
MNTSMomentus Inc
$ 0.86
(65.38%)
135.54M
SMFLSmart for Life Inc
$ 5.93
(51.66%)
34.59M
MAXNMaxeon Solar Technologies Ltd
$ 2.0281
(-34.79%)
34.89M
NTNXNutanix Inc
$ 56.35
(-23.11%)
15.36M
SNOASonoma Pharmaceuticals Inc
$ 0.205
(-21.15%)
6.78M
KAVLKaival Brands Innovations Group Inc
$ 1.26
(-20.25%)
205.94k
ONCOOnconetix Inc
$ 0.2368
(-19.70%)
15.96M
HLTHCue Health Inc
$ 0.0724
(32.12%)
583.02M
FFIEFaraday Future Intelligent Electric Inc
$ 0.563903
(26.95%)
582.94M
GWAVGreenwave Technology Solutions Inc
$ 0.04175
(-15.49%)
423.93M
CRKNCrown Electrokinetics Corporation
$ 0.113298
(28.75%)
277.58M
VERBVerb Technology Company Inc
$ 0.1572
(-2.48%)
166.17M

Your Recent History

Delayed Upgrade Clock